License, Collaboration and Other Significant Agreements - Deferred Revenues Balance (Details) - USD ($) $ in Thousands |
Dec. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Deferred Revenue: | ||
Short-term deferred revenue | $ 3,738 | $ 20,906 |
Long-Term | 43,296 | $ 21,474 |
Total | 47,034 | |
MTPC | MTPC | ||
Deferred Revenue: | ||
Short-term deferred revenue | 3,738 | |
Long-Term | 0 | |
Total | 3,738 | |
Vifor Pharma | ||
Deferred Revenue: | ||
Short-term deferred revenue | 0 | |
Long-Term | 43,296 | |
Total | $ 43,296 |
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|